Author Page for Jonathan Javitt

VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

Downloads 7,942 ( 1,138)

Citation 2

2

VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

Number of pages: 13 Posted: 04 Aug 2020 Last Revised: 05 Oct 2021

Jihad G. Youssef, Jonathan Javitt, Philip Lavin, Mukhtar Al-Saadi, Faisal Zahiruddin, Sarah Beshay, Mohammad Bitar, Joseph Kelley and Mohi Sayed

Houston Methodist Research Institute, Johns Hopkins School of Medicine, Boston Biostatistical Research Foundation, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital and Houston Methodist Hospital

Downloads 6,813 (1,475)

Abstract:

Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide

Number of pages: 10 Posted: 18 Sep 2020

Jihad G. Youssef, Mukthar Al-Saadi, Faisal Zahiruddin, Sarah Beshay, Mohammad Bitar and Jonathan Javitt

Houston Methodist Research Institute, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital, Houston Methodist Hospital and Johns Hopkins School of Medicine

Downloads 1,129 (27,094)

Abstract:

2.

Intravenous Aviptadil Is Associated with Increased Recovery and Survival in Patients with COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial

Number of pages: 17 Posted: 11 May 2021 Last Revised: 22 Aug 2021

Jihad G. Youssef, Richard Lee, Jonathan Javitt, Philip Lavin, Rainer Lenhardt, David J. Park, Javier Perez Fernandez, Melvin Morganroth and Dushyantha Jayaweera

Houston Methodist Research Institute, University of California, Irvine, Johns Hopkins School of Medicine, Boston Biostatistical Research Foundation, University of Louisville School of Medicine, Providence St. Jude Medical Center/St. Joseph Health Care, Medical Director, Critical Care, Oregon Clinic and University of Miami - Miller School of Medicine

Downloads 3,880 (3,892)

Citation 1

Abstract:

3.

VIP: A COVID-19 Therapeutic that Blocks Coronavirus Replication

Number of pages: 9 Posted: 12 Aug 2020 Last Revised: 29 Oct 2020

Jonathan Javitt and Jihad G. Youssef

Johns Hopkins School of Medicine and Houston Methodist Research Institute

Downloads 1,182 (25,744)

Citation 3

Abstract:

4.

Treatment of Sepsis-related Acute Respiratory Distress Syndrome with Vasoactive Intestinal Peptide

Number of pages: 11 Posted: 07 Aug 2020 Last Revised: 19 Aug 2020

Jihad G. Youssef, Sami Said, George Youssef, Matthew J. Javitt and Jonathan Javitt

Houston Methodist Research Institute, State University of New York (SUNY), Stony Brook (desceased), University of Houston, New York University (NYU) - Langone Medical Center and Johns Hopkins School of Medicine

Downloads 268 (162,848)

Citation 4

Jonathan Javitt

Johns Hopkins School of Medicine

Adjunct Professor

Potomac Institute for Policy Studies

NeuroRx

4

Top 4,368

13,272

9

2

Scholarly Papers (4)

VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

Abstract:

Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide

Abstract:

Intravenous Aviptadil Is Associated with Increased Recovery and Survival in Patients with COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial

Abstract:

VIP: A COVID-19 Therapeutic that Blocks Coronavirus Replication

Abstract:

Treatment of Sepsis-related Acute Respiratory Distress Syndrome with Vasoactive Intestinal Peptide

Abstract: